HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION

EIN: 411855605 501(c)(3) Diseases & Disorders

DENVILLE, NJ

Total Revenue
$1,326,262
Total Expenses
$1,080,476
Total Assets
$1,398,852
Net Assets
$1,151,960
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1996
Legal Domicile
NJ
Principal Officer
LISA SALBERG
Phone
9739837429
Tax Period
2023-01-01 to 2023-12-31

HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION, founded in 1996, is a community nonprofit in the Diseases & Disorders sector that reported $1.3M in total revenue in fiscal year 2023. Revenue grew 20% year-over-year, indicating healthy expansion. The organization ran a surplus of $246K, a strong 19% operating margin.

Mission

TO PROVIDE SUPPORT, ADVOCACY AND EDUCATION TO PATIENTS, FAMILIES, THE MEDICAL COMMUNITY AND THE PUBLIC ABOUT HYPERTROPHIC CARDIOMYOPATHY, WHILE SUPPORTING RESEARCH AND FOSTERING THE DEVELOPMENT OF TREATMENTS.

Program Service Accomplishments

Program 1
Expenses: $227,422 Revenue: $142,181

HCMA RECOGNIZED CENTER OF EXCELLENCE PROGRAM:HYPERTROPHIC CARDIOMYOPATHY IS A COMPLICATED DIAGNOSIS REQUIRING SPECIALTY MANAGEMENT STRATEGIES. HCM IMPACTS AN ESTIMATED ONE IN 250 IN THE GENERAL...

Read more

HCMA RECOGNIZED CENTER OF EXCELLENCE PROGRAM:HYPERTROPHIC CARDIOMYOPATHY IS A COMPLICATED DIAGNOSIS REQUIRING SPECIALTY MANAGEMENT STRATEGIES. HCM IMPACTS AN ESTIMATED ONE IN 250 IN THE GENERAL POPULATION. IT IS CURRENTLY SIGNIFICANTLY UNDERDIAGNOSED, WITH ONLY AN ESTIMATED 150,000 INDIVIDUALS IN THE UNITED STATES CURRENTLY IN TREATMENT FOR THE DISEASE. CARE FOR HCM REQUIRES MULTIPLE SUBSPECIALTY CARE MODALITIES INCLUDING BUT NOT LIMITED TO IMAGING CARDIOLOGY, INTERVENTIONAL CARDIOLOGY, ELECTROPHYSIOLOGY, CARDIAC SURGERY, GENETICS, PSYCHOSOCIAL SERVICES, AND CARDIAC OVERSIGHT FOR NONCARDIAC PROCEDURES, INCLUDING PREGNANCY ORTHOPEDIC ISSUES AND OTHER GENERAL MEDICAL NEEDS. THE HCMA HAS 50 RECOGNIZED CENTERS OF EXCELLENCE PROGRAMS IN THE UNITED STATES, WITH 17 UNDER REVIEW AND INTERNATIONAL PROGRAMMING BEING DEVELOPED. CREATION OF THESE PROGRAMS TAKES RELATIONSHIP BUILDING, PROGRAM EVALUATION AND ADMINISTRATIVE SUPPORT. PATIENTS CARED FOR IN THIS MODEL HAVE BETTER OUTCOMES THAN THOSE TREATED IN LOW-VOLUME CENTERS. THIS PROGRAM DIRECTLY LEADS TO PATIENT SAFETY AND OPTIMAL OUTCOMES.

Program 2
Expenses: $112,804 Revenue: $3,634

HCMA PATIENT INTAKE AND NAVIGATION SERVICES:THE HCMA ALLOWS EACH INDIVIDUAL DIAGNOSED WITH THE CONDITION TO CONTACT THE OFFICE (PHONE, EMAIL , IN PERSON, OR ONLINE THROUGH VIDEO CONFERENCING) AND...

Read more

HCMA PATIENT INTAKE AND NAVIGATION SERVICES:THE HCMA ALLOWS EACH INDIVIDUAL DIAGNOSED WITH THE CONDITION TO CONTACT THE OFFICE (PHONE, EMAIL , IN PERSON, OR ONLINE THROUGH VIDEO CONFERENCING) AND PARTICIPATE IN AN INTAKE CALL, WHICH THEN ALLOWS FOR UNDERSTANDING WHERE THE INDIVIDUAL IS COMING TO US REGARDING THEIR DISEASE PROCESS, ACCESS TO SPECIALTY CARE, EMOTIONAL SUPPORT, ADVOCACY SERVICES, AND MORE. THIS IS A VERY LABOR-INTENSIVE PORTION OF OUR WORK, REQUIRING INDIVIDUAL COMMUNICATION AND FOLLOW-UP. WE HAVE USED THIS MODEL OF SERVICE SINCE OUR FOUNDING IN 1996. IT HAS EVOLVED AS THE ORGANIZATION HAS, AND TO DATE, 20,000 INDIVIDUALS HAVE PARTICIPATED IN THE PROCESS.

Program 3
Expenses: $37,739 Revenue: $37,739

PATIENT EDUCATION BIGHEARTED WARRIOR WEBINAR PROGRAM:IN 2020, WE MOVED TO A VIRTUAL EDUCATION MODEL, WHICH HAS NOW SPANNED NEARLY FOUR YEARS WITH OVER 30 SEGMENTS OF EDUCATIONAL MATERIAL CREATED...

Read more

PATIENT EDUCATION BIGHEARTED WARRIOR WEBINAR PROGRAM:IN 2020, WE MOVED TO A VIRTUAL EDUCATION MODEL, WHICH HAS NOW SPANNED NEARLY FOUR YEARS WITH OVER 30 SEGMENTS OF EDUCATIONAL MATERIAL CREATED. EACH WEBINAR IS ORGANIZED BY EITHER THE HCMA-RECOGNIZED CENTER OR THE SUBTOPICS SUCH AS PEDIATRICS, GENETICS, OR OTHER SIMILAR TOPICS. THESE PROGRAMS ARE FREE TO ALL AND HAVE PROVIDED AN EDUCATIONAL OPPORTUNITY REGARDLESS OF GEOGRAPHIC LOCATION. THESE PROGRAMS ARE HELD TYPICALLY MONTHLY AND SOMETIMES MORE OFTEN THAN THAT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $979,965
Program Service Revenue $247,716
Investment Income $10,816
Other Revenue $87,765
TOTAL REVENUE $1,326,262

Expense Breakdown

Grants Paid $0
Salaries & Benefits $605,349
Fundraising Expenses $58,068
Program Expenses $717,022
Other Expenses $475,127
TOTAL EXPENSES $1,080,476

Year-over-Year Comparison

2023 2022 Change
Revenue $1,326,262 $1,106,885 +0.2%
Expenses $1,080,476 $796,317 +0.4%
Net Income $245,786 $310,568 -0.2%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
13
Independent Members
12
Employees
13
Volunteers
100

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$105,000
Total Directors
13
$105,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LISA SALBERG CEO/VICE CHAIR 40.00
Officer Director
$98,908 $6,092 $105,000
GORDON FOX PHD CHAIR 10.00
Officer Director
$0 $0 $0
ADAM SALBERG SECRETARY 1.00
Officer Director
$0 $0 $0
ROB LORFINK TREASURER 1.00
Officer Director
$0 $0 $0
AMIT KALIA PHD DIRECTOR 2.00
Director
$0 $0 $0
ROSEMARY CONLON DIRECTOR 1.00
Director
$0 $0 $0
BILLUR DOWSE DIRECTOR 10.00
Director
$0 $0 $0
MARTIN MARON MD DIRECTOR 2.00
Director
$0 $0 $0
MIKE LYNCH MD DIRECTOR 1.00
Director
$0 $0 $0
KEVIN O'CONNOR MD DIRECTOR 1.00
Director
$0 $0 $0
ISAAC RODRIGUEZ-CHAVEZ PHD MHS MS DIRECTOR 1.00
Director
$0 $0 $0
BILL ROSSI DIRECTOR 1.00
Director
$0 $0 $0
RICHARD MELIA PHD EMERITUS DIRECTOR 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $1,326,262 $1,080,476 $1,398,852 $245,786
2022 $1,106,885 $796,317 $1,085,584 $310,568
2021 $804,960 $531,813 $577,031 $273,147
2020 $390,972 $374,280 $313,163 $16,692
2019 $320,578 $191,775 $296,471 $128,803
2018 $355,678 $192,098 $167,668 $163,580
Explore More Nonprofits
Top 100 Nonprofits in New Jersey Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare HYPERTROPHIC CARDIOMYOPATHY ASSOCIATION with other nonprofits in New Jersey and across the country.